Uncategorized « Bioanalytical Sciences Group

On distributions of scientific activity and productivity

This is an update of a blog (as the first three paragraphs, here slightly modified and updated) that I wrote on January 11th, 2009 when I was Chief Executive at BBSRC. It raises generally interesting points that are seemingly not well known, and that – based on a number of recent discussions – I consider […]

Fibrinaloid microclots in Long COVID: assessing the actual evidence properly rather than pretending that it doesn’t exist

Introduction

The journal Research Practice in Thrombosis and Haemostasis recently chose to publish an opinion piece [1] under the title “Challenging the current hypothesis that thrombosis is responsible for the post-COVID-19 condition”, focusing on the theory (and in our cases the experimental measurement) of fibrinaloid microclots in the plasma of patients with Long COVID and […]

The aetiological involvement of fibrin amyloid microclots in PASC/Long COVID; the clots thicken

On July 24th, 2023, the Journal of Thrombosis and Haemostasis preprinted an article [1] by Connors and Ariëns entitled “Uncertainties about the Roles of Anticoagulation and Microclots in Post-acute Sequelae of SARS-CoV-2 Infection”. While it is not entirely clear what were either the motivation or purposes of that article (referred to as a ‘concept’ under […]

Bioanalytical Sciences Group

On distributions of scientific activity and productivity

Fibrinaloid microclots in Long COVID: assessing the actual evidence properly rather than pretending that it doesn’t exist

The aetiological involvement of fibrin amyloid microclots in PASC/Long COVID; the clots thicken

Google Search

Liverpool University

Institute of Systems, Molecular and Integrative Biology